Dr. Jorge E. Cortes CML Chronic Myeloid Leukemia
NEW POSITION: Incoming director of the Georgia Cancer Center at Augusta University, Georgia
CURRENT POSITION: Deputy chairman of department of leukemia at the University of Texas’ MD Anderson Cancer Center in Houston
CURRENT POSITION: Deputy chairman of department of leukemia at the University of Texas’ MD Anderson Cancer Center in Houston
''Jorge Cortes, MD, is deputy chair and professor of medicine in the Department of Leukemia at The University of Texas MD Anderson Cancer Center, Houston Texas where he directs the CML Program.''
Extract from the site of iCMLf (International Chronic Myeloid Leukemia Foundation).
VIDEOS
Treatment-Free Remission & Toxicities of Discontinuing CML Therapy
July 19, 2019, Targeted Oncology
Dr. Cortes Discusses TKI Cessation in CML
September 13, 2018, OncLiveTV
PACE Trial: Phase II trial of ponatinib in patients with chronic myeloid leukaemia (CML)
January16, 2018, ecancer
Jorge Cortes, MD, shares data presented at ASH 2017 regarding bosutinib in CML treatment
December 18, 2017, OBRoncology
Meet leukemia oncologist Jorge Cortes
October 25, 2017, MD Anderson Cancer Center
Faster, Better, Safer—Getting CML Treatment Right
December 23, 2016, PeerView Oncology
Study Brings Positive Results For the Most Resistant Types of CML
December 11, 2012, Patient Power
Dr. Jorge Cortes Discusses the Ponatinib Ph+All and CML Evaluation (PACE) Trial
June 14, 2012, OncLive
New Help for More CML Patients: Dr. Jorge Cortes
December 20, 2010, Patient Power
CML: The Current Landscape - an interview with Dr. Jorge Cortes
October 2010, The National CML Society (US)
CML Treatment: Old Drug, New Name
December 18, 2009, ElsGlobalMedicalNews
ARTICLES
13 physicians named America’s Top Doctors for 2019
March 29, 2019, Augusta University
Cancer center’s new chief starts transition
March 11, 2019, The Augusta Chronicle
Dr. Jorge Cortes - Renowned clinical investigator selected as director for the Georgia Cancer Center
February 27, 2019, Augusta University
FDA Approves Bosutinib for Newly-Diagnosed Ph+ CML
December 19, 2017, OncLive
Dr. Jorge Cortes Joins Dr. Andre Goy and Dr. Sagar Lonial as Co-Chair for the Landmark Physicians’ Education Resource® International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma
September 06, 2017, Business Wire
How I treat newly diagnosed chronic phase CML
August 16, 2012, Journal Blood
13 physicians named America’s Top Doctors for 2019
March 29, 2019, Augusta University
Cancer center’s new chief starts transition
March 11, 2019, The Augusta Chronicle
Dr. Jorge Cortes - Renowned clinical investigator selected as director for the Georgia Cancer Center
February 27, 2019, Augusta University
FDA Approves Bosutinib for Newly-Diagnosed Ph+ CML
December 19, 2017, OncLive
Dr. Jorge Cortes Joins Dr. Andre Goy and Dr. Sagar Lonial as Co-Chair for the Landmark Physicians’ Education Resource® International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma
September 06, 2017, Business Wire
How I treat newly diagnosed chronic phase CML
August 16, 2012, Journal Blood
